Serum Institute - The Purbottar

04 Jun

Serum Institute of India sought indemnity protection against prosecution

editor0 CommentsNorth EastCovid-19 vaccine, Covishield, Niti Aayog, Serum Institute

Serum Institute of India has sought indemnity protection against prosecution arising from any adverse effects for people taking its Covishield vaccine. The Centre, which has come under severe criticism for the slow progress of inoculation, expects to vaccinate one billion people by the end of this calendar year. Niti Aayog member (health) V. K. Paul had recently said that Pfizer’s Covid-19 vaccine is likely to be available in India from July. The pharma giant could supply around 5 crore doses between July and October, but it has harped on indemnity as a major requirement. Mumbai-based firm Cipla, which is looking…

Never exported Covid-19 vaccine at cost of people in India: Adar Poonawalla

editor0 CommentsHealthAdar Poonawalla, Serum Institute, Vaccine

Serum Institute chief Adar Poonawalla today said his firm has "never exported vaccines at the cost of the people of India". India's vaccination drive, he said, cannot be completed in two or three months given the huge population. It is Important to "stay united to fight the pandemic", read his statement in which he also pointed out that India is now receiving support from nations where vaccines, medicines were exported. The statement, Mr Poonawalla also explained the circumstances in which consignments of vaccines were sent abroad and the commitments made by the government in the initial stages of the pandemic…

Delhi govt seeks help from Serum Institute mentioning the non-availability of vaccines

editor0 CommentsBusiness, HealthCovid-19, Delhi, Health, INDIA, Serum Institute, Vaccine

Delhi government has written to Pune-based Serum Institute of India to "come to its rescue", adding it has a week's stock of Covishield for 18-44 years. The letter further mentioned that vaccination centres will have to be shut down due to the non-availability of vaccines. This letter came after Hyderabad-based Bharat Biotech stated it cannot supply more vaccine doses to Delhi. The Serum Institute replied to this and said that they are doing their best to meet countrywide vaccine requirements. "We rely on your support for provision of sufficient quantities of vaccine in a time-bound manner. Delhi has a limited…